146 related articles for article (PubMed ID: 21315779)
1. Adjuvant effect of cationic liposomes and CpG depends on administration route.
Slütter B; Bal SM; Ding Z; Jiskoot W; Bouwstra JA
J Control Release; 2011 Sep; 154(2):123-30. PubMed ID: 21315779
[TBL] [Abstract][Full Text] [Related]
2. Co-encapsulation of antigen and Toll-like receptor ligand in cationic liposomes affects the quality of the immune response in mice after intradermal vaccination.
Bal SM; Hortensius S; Ding Z; Jiskoot W; Bouwstra JA
Vaccine; 2011 Jan; 29(5):1045-52. PubMed ID: 21129393
[TBL] [Abstract][Full Text] [Related]
3. Small is beautiful: N-trimethyl chitosan-ovalbumin conjugates for microneedle-based transcutaneous immunisation.
Bal SM; Slütter B; Jiskoot W; Bouwstra JA
Vaccine; 2011 May; 29(23):4025-32. PubMed ID: 21443959
[TBL] [Abstract][Full Text] [Related]
4. Enhanced transcutaneous immunization via dissolving microneedle array loaded with liposome encapsulated antigen and adjuvant.
Guo L; Chen J; Qiu Y; Zhang S; Xu B; Gao Y
Int J Pharm; 2013 Apr; 447(1-2):22-30. PubMed ID: 23410987
[TBL] [Abstract][Full Text] [Related]
5. Adjuvanted, antigen loaded N-trimethyl chitosan nanoparticles for nasal and intradermal vaccination: adjuvant- and site-dependent immunogenicity in mice.
Bal SM; Slütter B; Verheul R; Bouwstra JA; Jiskoot W
Eur J Pharm Sci; 2012 Mar; 45(4):475-81. PubMed ID: 22009113
[TBL] [Abstract][Full Text] [Related]
6. Antigen-adjuvant nanoconjugates for nasal vaccination: an improvement over the use of nanoparticles?
Slütter B; Bal SM; Que I; Kaijzel E; Löwik C; Bouwstra J; Jiskoot W
Mol Pharm; 2010 Dec; 7(6):2207-15. PubMed ID: 21043518
[TBL] [Abstract][Full Text] [Related]
7. Nasal vaccination with N-trimethyl chitosan and PLGA based nanoparticles: nanoparticle characteristics determine quality and strength of the antibody response in mice against the encapsulated antigen.
Slütter B; Bal S; Keijzer C; Mallants R; Hagenaars N; Que I; Kaijzel E; van Eden W; Augustijns P; Löwik C; Bouwstra J; Broere F; Jiskoot W
Vaccine; 2010 Aug; 28(38):6282-91. PubMed ID: 20638455
[TBL] [Abstract][Full Text] [Related]
8. Effect of sublingual administration with a native or denatured protein allergen and adjuvant CpG oligodeoxynucleotides or cholera toxin on systemic T(H)2 immune responses and mucosal immunity in mice.
Huang CF; Wang CC; Wu TC; Chu CH; Peng HJ
Ann Allergy Asthma Immunol; 2007 Nov; 99(5):443-52. PubMed ID: 18051215
[TBL] [Abstract][Full Text] [Related]
9. Co-encapsulation of an antigen and CpG oligonucleotides into PLGA microparticles by TROMS technology.
San Román B; Irache JM; Gómez S; Tsapis N; Gamazo C; Espuelas MS
Eur J Pharm Biopharm; 2008 Sep; 70(1):98-108. PubMed ID: 18501572
[TBL] [Abstract][Full Text] [Related]
10. Stable assemblies of cationic bilayer fragments and CpG oligonucleotide with enhanced immunoadjuvant activity in vivo.
Rozenfeld JH; Silva SR; Ranéia PA; Faquim-Mauro E; Carmona-Ribeiro AM
J Control Release; 2012 Jun; 160(2):367-73. PubMed ID: 22036878
[TBL] [Abstract][Full Text] [Related]
11. Liposome-encapsulated CpG oligodeoxynucleotides as a potent adjuvant for inducing type 1 innate immunity.
Suzuki Y; Wakita D; Chamoto K; Narita Y; Tsuji T; Takeshima T; Gyobu H; Kawarada Y; Kondo S; Akira S; Katoh H; Ikeda H; Nishimura T
Cancer Res; 2004 Dec; 64(23):8754-60. PubMed ID: 15574787
[TBL] [Abstract][Full Text] [Related]
12. Co-delivery of ovalbumin and CpG motifs into microparticles protected sensitized mice from anaphylaxis.
San Román B; Irache JM; Gómez S; Gamazo C; Espuelas S
Int Arch Allergy Immunol; 2009; 149(2):111-8. PubMed ID: 19127067
[TBL] [Abstract][Full Text] [Related]
13. Orally administered OVA/CpG-ODN induces specific mucosal and systemic immune response in young and aged mice.
Alignani D; Maletto B; Liscovsky M; Rópolo A; Morón G; Pistoresi-Palencia MC
J Leukoc Biol; 2005 Jun; 77(6):898-905. PubMed ID: 15758079
[TBL] [Abstract][Full Text] [Related]
14. Mucosal adjuvant activity of oligomannose-coated liposomes for nasal immunization.
Ishii M; Kojima N
Glycoconj J; 2010 Jan; 27(1):115-23. PubMed ID: 19816665
[TBL] [Abstract][Full Text] [Related]
15. Dual role of CpG as immune modulator and physical crosslinker in ovalbumin loaded N-trimethyl chitosan (TMC) nanoparticles for nasal vaccination.
Slütter B; Jiskoot W
J Control Release; 2010 Nov; 148(1):117-121. PubMed ID: 20600405
[TBL] [Abstract][Full Text] [Related]
16. Mucosal and systemic immune responses by intranasal immunization using archaeal lipid-adjuvanted vaccines.
Patel GB; Zhou H; Ponce A; Chen W
Vaccine; 2007 Dec; 25(51):8622-36. PubMed ID: 17959279
[TBL] [Abstract][Full Text] [Related]
17. Administration routes affect the quality of immune responses: A cross-sectional evaluation of particulate antigen-delivery systems.
Mohanan D; Slütter B; Henriksen-Lacey M; Jiskoot W; Bouwstra JA; Perrie Y; Kündig TM; Gander B; Johansen P
J Control Release; 2010 Nov; 147(3):342-9. PubMed ID: 20727926
[TBL] [Abstract][Full Text] [Related]
18. The adjuvant mechanism of cationic dimethyldioctadecylammonium liposomes.
Korsholm KS; Agger EM; Foged C; Christensen D; Dietrich J; Andersen CS; Geisler C; Andersen P
Immunology; 2007 Jun; 121(2):216-26. PubMed ID: 17302734
[TBL] [Abstract][Full Text] [Related]
19. Chitosan and trimethyl chitosan chloride (TMC) as adjuvants for inducing immune responses to ovalbumin in mice following nasal administration.
Boonyo W; Junginger HE; Waranuch N; Polnok A; Pitaksuteepong T
J Control Release; 2007 Aug; 121(3):168-75. PubMed ID: 17644205
[TBL] [Abstract][Full Text] [Related]
20. CpG-DNA stimulates cellular and humoral immunity and promotes Th1 differentiation in aged BALB/c mice.
Maletto B; Rópolo A; Morón V; Pistoresi-Palencia MC
J Leukoc Biol; 2002 Sep; 72(3):447-54. PubMed ID: 12223511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
